Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Six healthcare trends expected in 2018
Like last year, 2018 is expected to bring about further uncertainty and risk for America’s healthcare industry. Issues like the healthcare act, tax reform, cybersecurity, and a marked increase in opioid deaths will shape the future of the healthcare sector
Universal health coverage in Africa and the public good
Associate Professor at University of Oslo, Dr Ruth J. Prince provides an overview of universal health coverage (UHC) and why this is important in Africa when it comes to the state, citizenship, healthcare and welfare
Universal health coverage (UHC)
The World Health Organization’s universal health coverage (UHC) initiative, plus the expansion of health insurance in Africa are explored here by Open Access Government
Tackling the healthcare challenge of diabetes in England
The work of NHS England in tackling one of the biggest healthcare challenges of our time, diabetes, is examined here by Open Access Government
Access to rare disease therapies in Europe
Simone Boselli, Public Affairs Director of EURORDIS shares the fascinating findings of a new position paper that offers a synthesis of their analysis, reflections and perspectives on access to rare disease therapies in Europe today
The role of advanced technologies in healthcare
The role of advanced technologies in healthcare, including the work of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in this area, is placed under the spotlight by Open Access Government
The health effects of exposure to chemicals and other substances
Open Access Government details the work of the National Toxicology Program, a world leader in providing scientific information to help evaluate and better understand the potential health effects of exposure to chemicals and other substances
How is blockchain disrupting health and wellness?
Distributed and open technologies are bringing new business models, personalisation, prediction, motivation, collaboration and trust in healthcare, in the view of Sari Stenfors from the ReCon Blockchain Research Project, at Aalto University in Finland
Diabetes & peripheral arterial disease
A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna
How right-sizing regulation can optimise plant protection
Greg Rosenthal of the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service explains how right-sizing regulation can optimise plant protection
Sunlight-induced carcinogenesis: Angiogenesis in skin cancer progression
Dr Olga V Volpert’s work on sunlight-induced carcinogenesis at the MD Anderson Cancer Center is explored here, including why angiogenesis is critically important in skin cancer progression
Cancer research and training in the United States
The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government
Accelerating innovative treatment for type 2 diabetes
Researchers from the University of Oxford and Novo Nordisk are collaborating to develop better treatments for type 2 diabetes
The illusion of cancer and death: Illusion of the self
Sumith A Kularatne, PhD, discusses his thoughts on the illusion of cancer and death
How trusted data is helping to liberate the power of medical cannabis
Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information
Duchenne muscular dystrophy (DMD)
Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
Acute myeloid leukaemia (AML) research and application
The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida
Diabetes: The fastest growing health crisis of our time
Head of Policy, Knowledge and Insight at Diabetes UK, Robin Hewings sheds light on the condition of diabetes in the UK today.
Empowering pathologists with artificial intelligence (AI)
Anna Knuuttila, Senior Scientist and Kaisa Helminen, CEO of Fimmic explain how artificial intelligence (AI) empowers pathologists when it comes to cancer care.
Antimicrobial resistance (AMR): Why Europe still needs to talk about a preventable crisis
Michele Calabro’, European Health Management Association Policy and Communications Manager explains antimicrobial resistance (AMR), focussing on why Europe still needs to talk about a preventable crisis that could cause more deaths than cancer
